At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02591 INNOGEN-B
Not Yet Opened 11-05 16:08:17
3.760
+0.565
+17.68%
High3.830Low3.205Vol44.83M
Open3.205D1 Closing3.195Amplitude19.56%
Mkt Cap1.72BTradable Cap1.58BTotal Shares457.00M
T/O160.67MT/O Rate10.67%Tradable Shares420.29M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Innogen Pharmaceutical Names Jin Bai Vice President to Drive Commercialisation Strategy
Bulletin Express  ·  10-19
Innogen Pharmaceutical Names Jin Bai Vice President to Drive Commercialisation Strategy
Guangzhou Innogen Pharmaceutical Group Co - Appoints Jin Bai as Vice President Effective 19 October 2026
THOMSON REUTERS  ·  10-19
Guangzhou Innogen Pharmaceutical Group Co - Appoints Jin Bai as Vice President Effective 19 October 2026
Guangzhou Innogen Pharmaceutical Group Co - Xu Wenjie Resigns as Executive Director
THOMSON REUTERS  ·  10-16
Guangzhou Innogen Pharmaceutical Group Co - Xu Wenjie Resigns as Executive Director
Asian Penny Stocks To Watch In October 2026
Simply Wall St.  ·  10-15
Asian Penny Stocks To Watch In October 2026
INNOGEN-B: Cowin Capital Investment III Limited Disposes of Shares, Long Position Falls to 2.48%
HK Disclosure  ·  09-11
INNOGEN-B: Cowin Capital Investment III Limited Disposes of Shares, Long Position Falls to 2.48%
INNOGEN-B: Cowin China Growth Fund II, L.P. Disposes of Shares, Long Position Falls to 2.48%
HK Disclosure  ·  09-11
INNOGEN-B: Cowin China Growth Fund II, L.P. Disposes of Shares, Long Position Falls to 2.48%
INNOGEN-B: Cowin Capital Investment Limited Disposes of Shares, Long Position Falls to 2.48%
HK Disclosure  ·  09-10
INNOGEN-B: Cowin Capital Investment Limited Disposes of Shares, Long Position Falls to 2.48%
INNOGEN-B: Cowin Capital Investment II LTD Disposes of Shares, Long Position Falls to 2.48%
HK Disclosure  ·  09-10
INNOGEN-B: Cowin Capital Investment II LTD Disposes of Shares, Long Position Falls to 2.48%
INNOGEN-B: Li Huang Disposes of Shares, Long Position Falls to 4.66%
HK Disclosure  ·  09-10
INNOGEN-B: Li Huang Disposes of Shares, Long Position Falls to 4.66%
INNOGEN-B: Weihe Zheng Disposes of Shares, Long Position Falls to 4.66%
HK Disclosure  ·  09-10
INNOGEN-B: Weihe Zheng Disposes of Shares, Long Position Falls to 4.66%
INNOGEN-B: Li Huang Disposes of Shares, Long Position Falls to 5.9%
HK Disclosure  ·  09-09
INNOGEN-B: Li Huang Disposes of Shares, Long Position Falls to 5.9%
INNOGEN-B: Weihe Zheng Disposes of Shares, Long Position Falls to 5.9%
HK Disclosure  ·  09-09
INNOGEN-B: Weihe Zheng Disposes of Shares, Long Position Falls to 5.9%
INNOGEN-B: Cowin Capital Investment II LTD Disposes of Shares, Long Position Falls to 3.43%
HK Disclosure  ·  09-08
INNOGEN-B: Cowin Capital Investment II LTD Disposes of Shares, Long Position Falls to 3.43%
Innogen Pharmaceutical Leaders Pledge Additional Six-Month Lock-Up After IPO Restriction Ends
Bulletin Express  ·  09-07
Innogen Pharmaceutical Leaders Pledge Additional Six-Month Lock-Up After IPO Restriction Ends
INNOGEN-B Founders and Executives Commit to Voluntary Share Lock-up Period
Stock News  ·  09-07
INNOGEN-B Founders and Executives Commit to Voluntary Share Lock-up Period
Guangzhou Innogen Pharmaceutical Group Co - Founder and Senior Management Undertake Six-Month Lock-up from August 15, 2026
THOMSON REUTERS  ·  09-07
Guangzhou Innogen Pharmaceutical Group Co - Founder and Senior Management Undertake Six-Month Lock-up from August 15, 2026
INNOGEN-B: Cowin Capital Investment III Limited Disposes of Shares, Long Position Falls to 4.23%
HK Disclosure  ·  09-04
INNOGEN-B: Cowin Capital Investment III Limited Disposes of Shares, Long Position Falls to 4.23%
INNOGEN-B: Cowin China Growth Fund II, L.P. Disposes of Shares, Long Position Falls to 4.23%
HK Disclosure  ·  09-04
INNOGEN-B: Cowin China Growth Fund II, L.P. Disposes of Shares, Long Position Falls to 4.23%
INNOGEN-B: Cowin Capital Investment Limited Disposes of Shares, Long Position Falls to 4.23%
HK Disclosure  ·  09-04
INNOGEN-B: Cowin Capital Investment Limited Disposes of Shares, Long Position Falls to 4.23%
INNOGEN-B: Li Huang Disposes of Shares, Long Position Falls to 6.95%
HK Disclosure  ·  09-03
INNOGEN-B: Li Huang Disposes of Shares, Long Position Falls to 6.95%

Introduction

Company Name.
INNOGEN-B
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Guangzhou Innogen Pharmaceutical Group Co Ltd is a China-based investment holding company principally engaged in the research, development and commercialisation of pharmaceutical products. The Company is primarily engaged in the commercialization of innovative, humanized, long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. The Company is dedicated to developing therapies for diabetes and other metabolic diseases. The Company’s core product, Efsubaglutide Alfa (brand name: Diabegone), is used for the treatment of type 2 diabetes (T2D). The Company’s primary pipeline drug candidates include YN014, YN401, YN209, YN203, and YN202. The Company principally conducts its businesses in the domestic market.
Issue price:
--